3-Methoxy-4-(2-oxo-2-(pyrrolidin-1-yl)ethoxy)benzaldehyde

Catalog No. :
ACXHEN945
CAS No. :
760183-53-7
Molecular Formula :
C14H17NO4
Molecular Weight :
263.29

IUPAC Name:3-methoxy-4-(2-oxo-2-(pyrrolidin-1-yl)ethoxy)benzaldehyde

3-Methoxy-4-(2-oxo-2-(pyrrolidin-1-yl)ethoxy)benzaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$76.00Login to see priceInquiryInquiry
1g95%$136.00Login to see priceInquiryInquiry
5g95%$498.00Login to see priceInquiryInquiry
10g95%$908.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Methoxy-4-(2-oxo-2-(pyrrolidin-1-yl)ethoxy)benzaldehyde
IUPAC Name3-methoxy-4-(2-oxo-2-(pyrrolidin-1-yl)ethoxy)benzaldehyde
MDL No.MFCD06358687
Molecular FormulaC14H17NO4
Molecular Weight263.29
SMILESO=CC1=CC=C(OCC(N2CCCC2)=O)C(OC)=C1
InChI KeyWQPVWMPVTAJJCJ-UHFFFAOYSA-N
SynonymTIMTEC-BB SBB012095;3-METHOXY-4-(2-OXO-2-PYRROLIDIN-1-YL-ETHOXY)-BENZALDEHYDE;Benzaldehyde, 3-methoxy-4-[2-oxo-2-(1-pyrrolidinyl)ethoxy]-;3-Methoxy-4-[2-oxo-2-(1-pyrrolidinyl)ethoxy]benzaldehyde
CAS No.760183-53-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXHEN945 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHTLI546 route compound structure diagram
    ACHTLI5461660-19-1 In Stock
  4. Then
  5. ACXHEN945 route product structure diagram
    ACXHEN945760183-53-7
Inquiry

2. ACXHEN945 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXHEN945 route product structure diagram
    ACXHEN945760183-53-7
Inquiry

Comments (0)